ESH Video

#ESHBMFS2024 HAS BEEN GRANTED 15,5 CME CREDIT POINTS! REGISTER NOW!

October 15, 2024

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference:
BONE MARROW FAILURE AND
LEUKAEMIA PREDISPOSITION SYNDROMES

November 15-17, 2024
Paris, France
#ESHBMFS2024

 

Chairs: Carmem Bonfim (Curitiba), Tim Brümmendorf (Aachen), Antonio Risitano (Naples), Sharon Savage (Bethesda)

Scientific Committee: Beatrice Drexler (Basel), Carlo Dufour (Genova), Morag Griffin (Leeds), Régis Peffault de Latour (Paris)

With the support of the Severe Aplastic Anaemia Working Party of the EBMT, the EHA SWG on Granulocyte and Bone Marrow Failures and the International PNH Interest Group.

 


 

 

The conference has been approved for 
15,5 CME credit points
by the European Board for Accreditation in Haematology (EBAH)!

THE CONFERENCE STARTS NEXT MONTH!
DON'T DELAY: join us on November 15th

 

 

 


 
 
CONFERENCE'S MAIN SCIENTIFIC TOPICS:
• Stem cell biology
• Inherited predisposition to leukaemia
• Constitutional marrow failure 2
• Constitutional marrow failure 3: telomere biology diseases and others…
• AA & PNH: 1. Pathophysiology and diagnosis
• AA & PNH: 2. CHIP and clonal evolution in BMFS
• Treatment of aplastic anaemia
• Treatment of paroxysmal nocturnal haemoglobinuria
• Expanding areas in BMFS

 


 

On behalf of the European School of Haematology, the Severe Aplastic Anaemia Working Party of the EBMT, the EHA SWG on Granulocyte and Bone Marrow Failures and the International PNH Interest Group, we are pleased to invite you to the 3rd ESH-EBMT-EHA-IPIG Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes.


ABOUT THE CONFERENCE:

The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes will be of particular value for clinicians and non- clinical scientists, M.D. and Ph.D. of all ages interested in the biology, pathophysiology, diagnosis and treatment of bone marrow failure syndromes (BMFS) and leukaemia predisposition syndromes. We will not only discuss the standard of care in acquired but also inherited BMFS occurring in adult and paediatric patients, but particularly focus on new underlying principles and evolving new treatment strategies.

Read more...

 


 

The conference faculty

 

 

 


 

SCIENTIFIC PROGRAMME

MORE INFORMATION

 


 

With the support of*:

Major Conference Partners
*******

Level 1 Conference Partner
*******

Supporting Conference Partner
*******

 

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.